Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.

Literature DB >> 845789

Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: multiple-dose oral administration.

H G Boxenbaum, K A Geitner, M L Jack, W R Dixon, S A Kaplan.

Abstract

Entities: Gene

Mesh：

Substances：
Chlordiazepoxide

Year: 1977 PMID： 845789 DOI： 10.1007/BF01064807

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

10 in total

1. Do you need a pharmacokinetic model, and, if so, which one?

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1975-12

2. Statistical estimations in pharmacokinetics.

Authors: H G Boxenbaum; S Riegelman; R M Elashoff
Journal: J Pharmacokinet Biopharm Date: 1974-04

3. Intrasubject variation in elimination half-lives of drugs which are appreciably metabolized.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1973-04

4. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors: L Z Benet
Journal: J Pharm Sci Date: 1972-04 Impact factor: 3.534

5. Pharmacology of the metabolites of chlordiazepoxide and diazepam.

Authors: L O Randall; C L Scheckel; R F Banziger
Journal: Curr Ther Res Clin Exp Date: 1965-09

6. Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors: S Riegelman; J Loo; M Rowland
Journal: J Pharm Sci Date: 1968-01 Impact factor: 3.534

7. Pharmacokinetic model for chlordiazepoxide--HCl in the dog.

Authors: S A Kaplan; M Lewis; M A Schwartz; E Postma; S Cotler; C W Abruzzo; T L Lee; R E Weinfeld
Journal: J Pharm Sci Date: 1970-11 Impact factor: 3.534

Review 8. Hepatic vascular bed.

Authors: C V Greenway; R D Stark
Journal: Physiol Rev Date: 1971-01 Impact factor: 37.312

9. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.

Authors: H G Boxenbaum; K A Geitner; M L Jack; W R Dixon; H E Spiegel; J Symington; R Christian; J D Moore; L Weissman; S A Kaplan
Journal: J Pharmacokinet Biopharm Date: 1977-02

10. N-desmethyldiazepam: a new metabolite of chlordiazepoxide in man.

Authors: R Dixon; M A Brooks; E Postma; M R Hackman; S Spector; J D Moore; M A Schwartz
Journal: Clin Pharmacol Ther Date: 1976-10 Impact factor: 6.875

10 in total

9 in total

1. Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects.

Authors: F B Eatman; W A Colburn; H G Boxenbaum; H N Posmanter; R E Weinfeld; R Ronfeld; L Weissman; J D Moore; M Gibaldi; S A Kaplan
Journal: J Pharmacokinet Biopharm Date: 1977-10

Review 2. Clinical pharmacokinetics of non-opiate abused drugs.

Authors: U Busto; R Bendayan; E M Sellers
Journal: Clin Pharmacokinet Date: 1989-01 Impact factor: 6.447

3. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes.